This is a preview of subscription content, log in via an institution to check access.
References
Cairns JA, Shackley P (1994) Assessing value for money in medical screening. J Med Screening 1:39–44
Hart CR, Burke P (eds) (1992) Screening and surveillance in general practice. Churchill Livingstone, Edinburgh, as reviewed by NCH Stott, J Med Screening 1:74, 1994
Riggs BL, Melton LJ III, O'Fallon WM (1993) Toward optimal therapy of established osteoporosis: evidence that antiresorptive and formation-stimulating regimens decrease vertebral fracture rate by independent mechanisms. Proc. of 4th Int Symp on Osteoporosis. Christiansen C, Riis B (eds). Handelstrykkeriet Aalborg ApS, Aalborg, Denmark, pp 13–15
Melton LJ III, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL (1993) Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 8:1227–1233
Parfitt AM (1993) Pathophysiology of bone fragility. Proc 4th Int Symp on Osteoporosis and Consensus Development Confs. Christiansen C, Riis B (eds). Handelstrykkereit Aalborg ApS, Aalborg, Denmark, pp 164–166
Eriksen EF, Mosekilde L, Melsen F (1985) Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics. Bone 6:381–389
Meunier PJ, Galus K, Briancon D, Deouard C, Charhon SA (1983) Treatment of ideopathic osteoporosis with sodium fluoride. In: Frame B, Potts JT Jr (eds). Clinical disorders of bone and mineral metabolism. Excerpta Medica, Amsterdam, pp 360–363
Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR (1993) The effect of recombinant human (1–84) or synthetic human (1–34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Endocrinology 132:1577–1584
Lindsay R, Cosman F, Nieves J, Dempster DW, Shen V (1993) A controlled clinical trial of the effects of 1-34hPTH in estrogentreated osteoporotic women. J Bone Miner Res 8(suppl 1):s130
Riggs BL, Hodgson SW, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, Cedel SL, Melton LJ III (1990) Effect of fluoride treatment on vertebral fracture rate in osteoporosis women. N Engl J Med 322:802–809
Dure-Smith BA, Kraenzlin ME, Farley SM, Libanati CR, Schulz EE, Baylink DJ (1991) Fluoride therapy of osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action. Calcif Tissue Int 49(suppl):S64–72
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gruber, H.E., Farley, S.M. & Baylink, D.J. Predictions on future diagnosis and treatment of osteoporosis: Results and discussion of a recent opinion poll. Calcif Tissue Int 57, 83–85 (1995). https://doi.org/10.1007/BF00298424
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00298424